Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
AURO-ATOMOXETINE AURO PHARMA INC Resolved 80MG Updated Report 2025-11-16 270003
ROPIVACAINE HYDROCHLORIDE INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 2MG Updated Report 2025-11-15 271950
VORICONAZOLE FOR INJECTION FRESENIUS KABI CANADA LTD Resolved 200MG Updated Report 2025-11-15 271611
TROMBOJECT 3% OMEGA LABORATORIES LIMITED Resolved 30MG Updated Report 2025-11-15 206240
QUILLIVANT ER CHEWABLE TABLETS KYE PHARMACEUTICALS INC. Resolved 20MG Updated Report 2025-11-15 271115
ONDISSOLVE ODF TAKEDA CANADA INC Resolved 8MG Updated Report 2025-11-15 262736
ONDISSOLVE ODF TAKEDA CANADA INC Resolved 4MG Updated Report 2025-11-15 262746
APO-AMPHETAMINE XR APOTEX INC Resolved 20MG Updated Report 2025-11-15 264567
APO-AMPHETAMINE XR APOTEX INC Resolved 15MG Updated Report 2025-11-15 264576
APO-ESOMEPRAZOLE APOTEX INC Actual shortage 20MG New Report 2025-11-14 271937
APO-AMPHETAMINE XR APOTEX INC Actual shortage 30MG Updated Report 2025-11-14 264573
APO-AMPHETAMINE XR APOTEX INC Actual shortage 25MG Updated Report 2025-11-14 264570
APO-AMPHETAMINE XR APOTEX INC Actual shortage 10MG Updated Report 2025-11-14 264564
APO-AMPHETAMINE XR APOTEX INC Actual shortage 5MG Updated Report 2025-11-14 264561
APO-LEVOTHYROXINE APOTEX INC Resolved 50MCG Updated Report 2025-11-14 262425
APO-DASATINIB APOTEX INC Actual shortage 20MG Updated Report 2025-11-14 265269
CLINDOXYL GEL GLAXOSMITHKLINE INC Resolved 5% 1% Updated Report 2025-11-14 261877
METHOTREXATE INJECTION BP ACCORD HEALTHCARE INC Actual shortage 25MG Updated Report 2025-11-14 218309
METHOTREXATE INJECTION BP ACCORD HEALTHCARE INC Actual shortage 25MG Updated Report 2025-11-14 227100
METHOTREXATE SUBCUTANEOUS ACCORD HEALTHCARE INC Actual shortage 20MG Updated Report 2025-11-14 271316
BREVICON 1/35 TABLETS (28-DAY PACK) PFIZER CANADA ULC Anticipated shortage 1MG 0.035MG New Report 2025-11-14 271908
LOVENOX HP SANOFI-AVENTIS CANADA INC Actual shortage 150MG Updated Report 2025-11-14 271411
IMITREX GLAXOSMITHKLINE INC Anticipated shortage 5MG New Report 2025-11-14 271904
IMITREX GLAXOSMITHKLINE INC Anticipated shortage 20MG New Report 2025-11-14 271901
ENGERIX-B GLAXOSMITHKLINE INC Resolved 20MCG Updated Report 2025-11-14 269359
VOLIBRIS GLAXOSMITHKLINE INC Avoided shortage 5MG Updated Report 2025-11-14 267983
VOLIBRIS GLAXOSMITHKLINE INC Avoided shortage 10MG Updated Report 2025-11-14 267986
AURO-CEPHALEXIN AURO PHARMA INC Actual shortage 250MG Updated Report 2025-11-14 166586
AURO-CEPHALEXIN AURO PHARMA INC Actual shortage 125MG Updated Report 2025-11-14 219262
ACYCLOVIR SODIUM INJECTION EUGIA PHARMA INC. Actual shortage 50MG Updated Report 2025-11-14 270922
EUGIA-ONDANSETRON INJECTION EUGIA PHARMA INC. Actual shortage 2MG Updated Report 2025-11-14 257697
DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION EUGIA PHARMA INC. Actual shortage 100MCG Updated Report 2025-11-14 262460
BREVIBLOC INJECTION 10MG/ML BAXTER CORPORATION Resolved 10MG Updated Report 2025-11-14 263010
APO-TERBINAFINE APOTEX INC Actual shortage 250MG Updated Report 2025-11-13 269757
APO-DORZO-TIMOP APOTEX INC Actual shortage 20MG 5MG New Report 2025-11-13 271862
APO-DESVENLAFAXINE APOTEX INC Actual shortage 50MG Updated Report 2025-11-13 271859
APO-DILTIAZ CD APOTEX INC Actual shortage 240MG New Report 2025-11-13 271856
APO-GABAPENTIN APOTEX INC Actual shortage 600MG New Report 2025-11-13 271853
APO-CLOPIDOGREL APOTEX INC Actual shortage 75MG New Report 2025-11-13 271850
APO-SITAGLIPTIN/METFORMIN XR APOTEX INC Actual shortage 50MG 1000MG Updated Report 2025-11-13 271847
APO-CLOPIDOGREL APOTEX INC Actual shortage 75MG New Report 2025-11-13 271844
TIMOPTIC ELVIUM LIFE SCIENCES Actual shortage 0.5% Updated Report 2025-11-13 267762
BIPAZEN KVR PHARMACEUTICALS INC. Actual shortage 4MCG Updated Report 2025-11-13 260964
PMSC-ESOMEPRAZOLE DR PHARMASCIENCE INC Actual shortage 20MG New Report 2025-11-13 271837
PMSC-ESOMEPRAZOLE DR PHARMASCIENCE INC Actual shortage 40MG Updated Report 2025-11-13 270551
TEVA-RAMIPRIL TEVA CANADA LIMITED Actual shortage 10MG New Report 2025-11-13 271832
TEVA-ESOMEPRAZOLE TEVA CANADA LIMITED Actual shortage 20MG Updated Report 2025-11-13 264408
TEVA-SUMATRIPTAN DF TEVA CANADA LIMITED Resolved 100MG Updated Report 2025-11-13 263119
TEVA-NAPROXEN TEVA CANADA LIMITED Resolved 500MG Updated Report 2025-11-13 271205
TEVA-LENOLTEC NO. 4 TEVA CANADA LIMITED Resolved 60MG 300MG Updated Report 2025-11-13 255672

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
CLINDOXYL GEL GLAXOSMITHKLINE INC Discontinued 5% 1% Updated Report 2025-11-14 270515
GLUCOPHAGE SANOFI-AVENTIS CANADA INC To be discontinued 850MG New Report 2025-11-14 271873
ARAVA SANOFI-AVENTIS CANADA INC To be discontinued 10MG New Report 2025-11-14 271870
ARAVA SANOFI-AVENTIS CANADA INC To be discontinued 20MG New Report 2025-11-14 271867
KIVEXA VIIV HEALTHCARE ULC Discontinued 300MG 600MG Updated Report 2025-11-13 238375
SANDOZ ORPHENADRINE SANDOZ CANADA INCORPORATED Discontinued 100MG New Report 2025-11-13 271679
VOLTAREN OPHTHA NOVARTIS PHARMACEUTICALS CANADA INC Discontinued 0.1% New Report 2025-11-12 271635
HUMATROPE ELI LILLY CANADA INC To be discontinued 24MG 3.15ML Updated Report 2025-11-11 240682
HUMATROPE ELI LILLY CANADA INC To be discontinued 12MG 3.15ML Updated Report 2025-11-11 240679
HUMATROPE ELI LILLY CANADA INC To be discontinued 6MG 3.15ML Updated Report 2025-11-11 240676
TRUSOPT ELVIUM LIFE SCIENCES To be discontinued 2% Updated Report 2025-11-11 267941
ISENTRESS MERCK CANADA INC Discontinued 25MG Updated Report 2025-11-08 263516
ATIVAN PFIZER CANADA ULC Discontinued 2MG Updated Report 2025-11-03 269840
ATIVAN PFIZER CANADA ULC Discontinued 1MG Updated Report 2025-11-03 269837
ATIVAN PFIZER CANADA ULC Discontinued 0.5MG Updated Report 2025-11-03 269831
ATIVAN PFIZER CANADA ULC Discontinued 2MG Updated Report 2025-11-03 269826
CEENU BRISTOL-MYERS SQUIBB CANADA To be discontinued 10MG Updated Report 2025-10-31 137687
CEENU BRISTOL-MYERS SQUIBB CANADA To be discontinued 40MG Updated Report 2025-10-31 137690
IMITREX DF - TAB 50MG GLAXOSMITHKLINE INC Discontinued 50MG New Report 2025-10-30 270582
PANTOPRAZOLE T SANIS HEALTH INC Discontinued 40MG Updated Report 2025-10-28 270365